PRAMILA STANFORD: Open Payments
NPI 1831781434 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 12 payments from 6 companies in 2025. Trend: 2023 $3,852 · 2024 $1,686 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $386 |
| Alkermes, Inc. | 2 | $231 |
| ABBVIE INC. | 2 | $194 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Corium, LLC | 3 | $39 |
Products named: SPRAVATO, VRAYLAR, COBENFY, REXULTI, LYBALVI, VIVITROL, Azstarys.
Industry payments across OK — which companies pay providers there.
